Impact of Treatment Delay on Survival Outcomes for Patients With Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
Clin Genitourin Cancer 2021 Feb 01;19(1)41-46.e1, BW Fischer-Valuck, JM Michalski, JG Harton, A Birtle, JP Christodouleas, JA Efstathiou, VK Arora, EH Kim, EM Knoche, RK Pachynski, J Picus, YJ Rao, M Reimers, BJ Roth, P Sargos, ZL Smith, MS Zaghloul, HA Gay, SA Patel, BC BaumannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.